Maxim Khasnatinov

Dr. Maxim Khasnatinov

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GMGregory Moureau
Gregory Moureau
SCShelley Cook
Shelley Cook
PLPhilippe Lemey
Philippe Lemey
ANAntoine Nougairede
Antoine Nougairede
NFNaomi L Forrester
Naomi L Forrester
XLXavier De Lamballerie
Xavier De Lamballerie
To generate the most diverse phylogenetic dataset for the flaviviruses to date, we determined the genomic sequences and phylogenetic relationships of 14 flaviviruses, of which 10 are primarily associated with Culex spp. mosquitoes. We analyze these data, in conjunction with a comprehensive collection of flavivirus genomes, to characterize flavivirus evolutionary and biogeographic history in unprecedented detail and breadth. Based on the presumed introduction of yellow fever virus into the Americas via the transatlantic slave trade, we extrapolated a timescale for a relevant subset of flaviviruses whose evolutionary history, shows that different Culex-spp. associated flaviviruses have been introduced from the Old World to the New World on at least five separate occasions, with 2 different sets of factors likely to have contributed to the dispersal of the different viruses. We also discuss the significance of programmed ribosomal frameshifting in a central region of the polyprotein open reading frame in some mosquito-associated flaviviruses.

1 August 2010 in Antiviral Research
Verified
Journal Article
Closed access
EGErnest Gould
Ernest Gould
BCB. Coutard
B. Coutard
HMH. Malet
H. Malet
BMB. Morin
B. Morin
SJS. Jamal
S. Jamal
BCBruno Canard
Bruno Canard

5 October 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MKMaxim Khasnatinov
Maxim Khasnatinov
KUKatarina Ustanikova
Katarina Ustanikova
TFTatiana V. Frolova
Tatiana V. Frolova
VPVanda V. Pogodina
Vanda V. Pogodina
NBNadezshda G. Bochkova
Nadezshda G. Bochkova
TGTamara S. Gritsun
Tamara S. Gritsun
Tick-borne encephalitis virus (TBEV) causes human epidemics across Eurasia. Clinical manifestations range from inapparent infections and fevers to fatal encephalitis but the factors that determine disease severity are currently undefined. TBEV is characteristically a hemagglutinating (HA) virus; the ability to agglutinate erythrocytes tentatively reflects virion receptor/fusion activity. However, for the past few years many atypical HA-deficient strains have been isolated from patients and also from the natural European host tick, Ixodes persulcatus. By analysing the sequences of HA-deficient strains we have identified 3 unique amino acid substitutions (D67G, E122G or D277A) in the envelope protein, each of which increases the net charge and hydrophobicity of the virion surface. Therefore, we genetically engineered virus mutants each containing one of these 3 substitutions; they all exhibited HA-deficiency. Unexpectedly, each genetically modified non-HA virus demonstrated increased TBEV reproduction in feeding Ixodes ricinus, not the recognised tick host for these strains. Moreover, virus transmission efficiency between infected and uninfected ticks co-feeding on mice was also intensified by each substitution. Retrospectively, the mutation D67G was identified in viruses isolated from patients with encephalitis. We propose that the emergence of atypical Siberian HA-deficient TBEV strains in Europe is linked to their molecular adaptation to local ticks. This process appears to be driven by the selection of single mutations that change the virion surface thus enhancing receptor/fusion function essential for TBEV entry into the unfamiliar tick species. As the consequence of this adaptive mutagenesis, some of these mutations also appear to enhance the ability of TBEV to cross the human blood-brain barrier, a likely explanation for fatal encephalitis. Future research will reveal if these emerging Siberian TBEV strains continue to disperse westwards across Europe by adaptation to the indigenous tick species and if they are associated with severe forms of TBE.

10 July 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
NONamsrai Oyuntsetseg
Namsrai Oyuntsetseg
MKMaxim Khasnatinov
Maxim Khasnatinov
PMPerenlei Molor-Erdene
Perenlei Molor-Erdene
JOJanchiv Oyunbileg
Janchiv Oyunbileg
ALAleksander V Liapunov
Aleksander V Liapunov
CCChimedtseren Chimedragchaa
Chimedtseren Chimedragchaa
The herb formulation Deva-5 is used in traditional medicine to treat acute infectious diseases. Deva-5 is composed of five herbs: Gentiana decumbens L., Momordica cochinchinensis L., Hypecoum erectum L., Polygonum bistorta L., and Terminalia chebula Retz. Deva-5 and its five components were investigated for in vitro antiviral activity against avian influenza A virus subtype H3N8.

7 March 2014 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
NKNina V. Kulakova
Nina V. Kulakova
MKMaxim Khasnatinov
Maxim Khasnatinov
ESElena A. Sidorova
Elena A. Sidorova
Renat AdelshinRenat Adelshin
Renat Adelshin
SBSergei Belikov
Sergei Belikov

7 October 2015 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
MKMaxim Khasnatinov
Maxim Khasnatinov
ALAlexander Valeryevich Liapunov
Alexander Valeryevich Liapunov
EMEllina Lopsonovna Manzarova
Ellina Lopsonovna Manzarova
NKNina V. Kulakova
Nina V. Kulakova
IPIrina Viktorovna Petrova
Irina Viktorovna Petrova
GDGalina Anatolyevna Danchinova
Galina Anatolyevna Danchinova